Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

vaginal hyaluronic acid/lactic acid-based formulation IC-LC02S2Q2

A topical formulation containing hyaluronic acid and lactic acid, with vaginal healing, soothing, protective and immunomodulating activities. Upon intravaginal application of the hyaluronic acid/lactic acid-based formulation IC-LC02S2Q2, the hyaluronic acid enhances barrier integrity and barrier protection, reduces vaginal dryness while keeping the microbiome and pH levels normal. Lactic acid may protect the vagina by providing an acidic environment, which restores pH balance, helps provide an optimal vaginal microbiota, and enhances barrier integrity. This leads to immunomodulation and may prevent inflammation and infection. Altogether, this prevents vaginal itching, burning, bleeding, discomfort, and an unpleasant odor.
Synonym:topical hyaluronic acid/lactic acid IC-LC02S2Q2
vaginal hyaluronic acid/lactic acid IC-LC02S2Q2
Code name:IC LC02S2Q2
IC-LC02S2Q2
ICLC02S2Q2
Search NCI's Drug Dictionary